Trials / Sponsors / Lindis Biotech GmbH
Lindis Biotech GmbH
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC Urinary Bladder Neoplasms | Phase 1 | 2020-07-07 |